MESTINON
Generic: PYRIDOSTIGMINE BROMIDE
Bausch Health USManufacturer
ORALRoute
PYRIDOSTIGMINE BROMIDEActive Substance
1959-01-12Original Approval
MESTINON is FDA application NDA011665, sponsored by BAUSCH. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
MYASTHENIA GRAVIS
878 reports
2
FATIGUE
781 reports
3
DRUG INEFFECTIVE
635 reports
4
ASTHENIA
614 reports
5
OFF LABEL USE
598 reports
6
DIARRHOEA
565 reports
7
HEADACHE
537 reports
8
DYSPNOEA
527 reports
9
NAUSEA
480 reports
10
MUSCULAR WEAKNESS
410 reports